Edition:
United Kingdom

Astrazeneca Pharma India Ltd (ASTR.NS)

ASTR.NS on National Stock Exchange of India

2,204.95INR
24 May 2019
Change (% chg)

Rs-20.40 (-0.92%)
Prev Close
Rs2,225.35
Open
Rs2,243.30
Day's High
Rs2,267.25
Day's Low
Rs2,182.50
Volume
10,224
Avg. Vol
19,731
52-wk High
Rs2,397.70
52-wk Low
Rs1,108.85

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Dec 2,151.94 11.640
Sep 1,613.61 3.653
Jun 1,614.37 2.560
FY 2018 Mar '18 1,507.27 1.287
Dec 1,285.39 -4.141
Sep 1,642.58 10.954
Jun 1,284.66 2.320
FY 2017 Mar '17 1,168.86 -3.826
Dec 1,515.02 6.484
Sep 1,394.06 0.315
Jun 1,408.65 5.041
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 120.54 29.30 32.55
P/E High - Last 5 Yrs. 548.94 43.17 48.12
P/E Low - Last 5 Yrs. 95.66 22.71 23.41
Beta 0.50 0.86 0.87
Price to Sales (TTM) 4.49 6.59 8.43
Price to Book (MRQ) -- 5.12 5.27
Price to Tangible Book (MRQ) -- 5.84 6.74
Price to Cash Flow (TTM) 67.54 23.07 24.12
% Owned Institutions -- 0.87 1.65

Dividends

  Company industry sector
Dividend Yield -- 1.43 1.35
Dividend Yield - 5 Year Avg -- 1.45 1.37
Dividend 5 Year Growth Rate -- 4.00 4.71
Payout Ratio(TTM) 0.00 42.19 39.59

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -8.80 5.43 13.45
Sales (TTM) vs TTM 1 Yr. Ago -7.71 6.61 8.04
Sales - 5 Yr. Growth Rate 0.30 10.48 10.84
EPS (MRQ) vs Qtr. 1 Yr. Ago -53.97 45.66 47.76
EPS (TTM) vs TTM 1 Yr. Ago 30.10 -- --
EPS - 5 Yr. Growth Rate 4.34 9.90 10.46
Capital Spending - 5 Yr. Growth Rate -32.37 15.26 14.68

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.07 2.18
Current Ratio (MRQ) -- 2.87 2.98
LT Debt to Equity (MRQ) -- 8.86 11.34
Total Debt to Equity (MRQ) -- 12.87 16.04
Interest Coverage (TTM) -- 32.47 28.45

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 66.88 52.11 52.39
Gross Margin - 5 Yr. Avg. 58.94 49.67 50.39
EBITD Margin (TTM) 3.71 -- --
EBITD - 5 Yr. Avg -1.89 17.26 12.41
Operating Margin (TTM) 0.79 13.53 5.67
Operating Margin - 5 Yr. Avg. -3.91 13.69 8.01
Pre-Tax Margin (TTM) 5.09 11.88 4.70
Pre-Tax Margin - 5 Yr. Avg. -2.10 14.09 8.29
Net Profit Margin (TTM) 3.72 8.79 1.43
Net Profit Margin - 5 Yr. Avg. -3.27 10.58 4.69
Effective Tax Rate (TTM) 26.88 22.13 22.13
Effective Tax Rate - 5 Yr. Avg. -- 22.26 22.58

Efficiency

  Company industry sector
Revenue/Employee (TTM) 4,631,859 928,433,188 819,677,428
Net Income/Employee (TTM) 172,405 105,143,011 92,782,969
Receivable Turnover (TTM) -- 5.84 5.82
Inventory Turnover (TTM) -- 2.57 3.42
Asset Turnover (TTM) -- 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 10.98 10.65
Return on Assets - 5 Yr. Avg. -4.28 12.41 11.78
Return on Investment (TTM) -- 14.23 13.82
Return on Investment - 5 Yr. Avg. -10.35 16.18 15.32
Return on Equity (TTM) -- 15.46 15.25
Return on Equity - 5 Yr. Avg. -10.64 17.07 16.41
  1 Year 3 Year 5 Year
Sales % -4.29 4.42 0.30
EPS (TTM) % 364.77 -- 4.34
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Astrazeneca Pharma India Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 2.27 1.86 99 29
13 Week -4.17 -5.54 99 42
26 Week 0.58 -6.08 99 43
52 Week 0.44 -11.26 99 11
YTD 2.48 -14.23 99 39
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.56%
# of Holders: 5
Total Shares Held: 1,140,255
3 Mo. Net Change: -271,835
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.